Goldman Sachs Group Inc Spdr Ser Tr Spdr S&P Pharmaceu Transaction History

Goldman Sachs Group Inc

$780 Billion
Q3 2025

A detailed history of Goldman Sachs Group Inc transactions in Spdr Ser Tr Spdr S&P Pharmaceu stock. As of the latest transaction made, Goldman Sachs Group Inc holds 111,294 shares of XPH stock, worth $5.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

111,294

Previous 114,331 2.66%

Holding current value

$5.65 Million

Previous $4.64 Million 15.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$40.76 - $47.94 $123,788 - $145,593	-3,037 Reduced 2.66%	111,294 $5.34 Million
Q2 2025 Aug 14, 2025	SELL	$36.65 - $42.44 $205,166 - $237,579	-5,598 Reduced 4.67%	114,331 $4.64 Million
Q1 2025 May 09, 2025	BUY	$42.3 - $45.81 $2.5 Million - $2.7 Million	59,007 Added 96.86%	119,929 $5.25 Million
Q4 2024 Feb 11, 2025	BUY	$42.71 - $48.29 $269,756 - $304,999	6,316 Added 11.57%	60,922 $2.62 Million
Q3 2024 Nov 14, 2024	BUY	$39.24 - $45.31 $571,020 - $659,351	14,552 Added 36.33%	54,606 $2.42 Million

Q2 2024 Aug 13, 2024	SELL	$39.09 - $42.64 $4.52 Million - $4.93 Million	-115,684 Reduced 74.28%	40,054 $1.59 Million
Q1 2024 May 15, 2024	BUY	$41.38 - $45.49 $2.31 Million - $2.54 Million	55,738 Added 55.74%	155,738 $6.72 Million
Q4 2023 Feb 13, 2024	SELL	$35.2 - $41.92 $2.71 Million - $3.23 Million	-77,043 Reduced 43.52%	100,000 $4.16 Million
Q3 2023 May 14, 2024	BUY	$39.75 - $44.12 $3.06 Million - $3.4 Million	77,043 Added 77.04%	177,043 $7.04 Million
Q3 2023 Nov 14, 2023	SELL	$39.75 - $44.12 $243,071 - $269,793	-6,115 Reduced 3.34%	177,043 $7.04 Million
Q2 2023 May 14, 2024	SELL	$39.1 - $42.57 $5.24 Million - $5.7 Million	-133,979 Reduced 42.25%	183,158 $7.51 Million
Q2 2023 Aug 14, 2023	SELL	$39.1 - $42.57 $5.24 Million - $5.7 Million	-133,979 Reduced 42.25%	183,158 $7.51 Million
Q1 2023 May 14, 2024	BUY	$39.61 - $44.25 $2 Million - $2.23 Million	50,437 Added 18.91%	317,137 $13 Million
Q1 2023 May 11, 2023	BUY	$39.61 - $44.25 $2 Million - $2.23 Million	50,437 Added 18.91%	317,137 $13 Million
Q4 2022 May 14, 2024	BUY	$40.06 - $43.59 $5.23 Million - $5.69 Million	130,565 Added 95.91%	266,700 $10.9 Million
Q4 2022 Feb 13, 2023	BUY	$40.06 - $43.59 $5.23 Million - $5.69 Million	130,565 Added 95.91%	266,700 $10.9 Million
Q3 2022 May 14, 2024	BUY	$39.59 - $44.52 $3.32 Million - $3.74 Million	83,941 Added 160.82%	136,135 $5.47 Million
Q3 2022 Nov 10, 2022	BUY	$39.59 - $44.52 $3.32 Million - $3.74 Million	83,941 Added 160.82%	136,135 $0
Q2 2022 May 14, 2024	SELL	$38.15 - $46.44 $1.82 Million - $2.22 Million	-47,806 Reduced 47.81%	52,194 $2.19 Million
Q2 2022 Aug 15, 2022	SELL	$38.15 - $46.44 $17.4 Million - $21.2 Million	-455,723 Reduced 89.72%	52,194 $2.19 Million
Q1 2022 May 16, 2022	SELL	$41.55 - $46.61 $2.88 Million - $3.23 Million	-69,261 Reduced 12.0%	507,917 $23 Million
Q4 2021 Feb 14, 2022	SELL	$43.72 - $52.45 $2.15 Million - $2.58 Million	-49,280 Reduced 7.87%	577,178 $26.6 Million
Q3 2021 Nov 10, 2021	BUY	$46.51 - $53.1 $29.1 Million - $33.3 Million	626,458 New	626,458 $29.7 Million

Others Institutions Holding XPH

# of Institutions

Shares Held

2.73M

Call Options Held

12K

Put Options Held

22.2K

View Full List

About SPDR SER TR SPDR S&P PHARMACEU

Ticker XPH
Sector ETFs
Industry ETFs

More about XPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Spdr Ser Tr Spdr S&P Pharmaceu Transaction History